Re-Focused Kiadis Preps Trials With Natural Killer Cells

Revamped Biotech Trialling NK-cells In AML and HSCT

Cancer_Cells
Kiadis is researching NK cells for their therapeutic potential • Source: Shutterstock

More from Clinical Trials

More from R&D